Contact us for more information or to book your assessment visit!

Find the specialized Gondola® Partner Center nearest you and book an appointment to assess your treatment response.

I am a*
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
  • All
  • GONDOLA
  • Other
  • Parkinson
  • Stroke
All
  • All
  • GONDOLA
  • Other
  • Parkinson
  • Stroke
Meet Mauro Santinato

Meet our responsible for the Production and Supply chain

Mauro Santinato has been part of the Dream Team for more than one year as Head of Production and Supply Chain, and last week he dedicated some of his time to talk with us.

Read more
Meet our SAB

Gondola appoints its scientific advisory board

We are thrilled to announce the appointment of our Scientific Advisory Board (SAB), whose mission is to provide guidance and scientific input on multiple aspects of our clinical activities as well as technology development of Gondola® Automated Mechanical Peripheral Stimulation (AMPS).

Read more

Improve your walking directly from your home

At Gondola, we aim to provide accessible therapy from the comfort of your home, especially in light of the challenges posed by the COVID-19 pandemic.

Read more

Gondola Medical Technologies and the renowned Mount Sinai Health System enter research collaboration

 Gondola Medical Technologies collaborates with the world-renowned Mount Sinai Health System in New York City (USA) to enhance the research on Automated Peripheral Mechanical Stimulation (AMPS) therapy.

Read more

The challenge of dual-tasking for Parkinson’s Disease patients

At Gondola Medical Technologies, we have observed that dual-tasking is a real challenge for many patients with neurological disorders like Parkinson’s Disease (PD). The ability to walk while simultaneously talking or thinking about a complex issue is easily taken for granted.

Read more

Gondola AMPS therapy – Is it based on science or magic?

Gondola Medical Technologies first launched the Gondola AMPS therapy for people with walking and balancing impairment due to neurological disorders in 2011. Since then, the company has successfully supported many Parkinson’s Disease patients in regaining their independence.

Read more

Biomechanics provides reliable evidence in the MedTech industry

In the MedTech industry, scientific evidence is essential to be authorized for use by regulatory bodies and to gain support from medical professionals. Biomechanics, the study of the movements and structures of living things using the science of mechanics, can help provide this evidence.

Read more

AMBITION: A clinical study focusing on “Freezing of Gait” (FOG)

The AMBITION clinical trial aims to investigate the safety and efficacy of the Gondola AMPS therapy in 40 Parkinson’s disease patients suffering from severe freezing of gait (FOG) symptoms, despite dopaminergic and deep brain stimulation (DBS) treatments. It is a particularly interesting population to use the Gondola AMPS therapy, as there are limited treatment options for FOG treatment

Read more

What is Freezing of Gait?

A large meta-analysis published last year (Zhang et al, 2021) reported that more than half of patients with Parkinson’s Disease …

Read more